Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Column Group (TCG) is a leading venture capital firm based in San Francisco that specializes in creating and building next-generation biotechnology companies. Unlike traditional investment firms, TCG often operates as a company-creation engine, partnering with elite scientific founders to launch startups around transformative biological insights. Through its internal R&D engine, TCG Labs, the firm provides operational and scientific support to advance early-stage programs toward clinical development. TCG has been instrumental in the founding of numerous high-profile biotechs, including NGM Biopharmaceuticals, Peloton Therapeutics, and ORIC Pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TCG Advisors.